These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

520 related articles for article (PubMed ID: 18438727)

  • 1. Dendritic spine loss and synaptic alterations in Alzheimer's disease.
    Knobloch M; Mansuy IM
    Mol Neurobiol; 2008 Feb; 37(1):73-82. PubMed ID: 18438727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amyloid beta: a putative intra-spinal microtubule-depolymerizer to induce synapse-loss or dentritic spine shortening in Alzheimer's disease.
    Mitsuyama F; Futatsugi Y; Okuya M; Karagiozov K; Peev N; Kato Y; Kanno T; Sano H; Koide T
    Ital J Anat Embryol; 2009; 114(2-3):109-20. PubMed ID: 20198823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synapses and dendritic spines as pathogenic targets in Alzheimer's disease.
    Yu W; Lu B
    Neural Plast; 2012; 2012():247150. PubMed ID: 22474602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble oligomers of the amyloid beta-protein impair synaptic plasticity and behavior.
    Selkoe DJ
    Behav Brain Res; 2008 Sep; 192(1):106-13. PubMed ID: 18359102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drebrin in Alzheimer's Disease.
    Ishizuka Y; Hanamura K
    Adv Exp Med Biol; 2017; 1006():203-223. PubMed ID: 28865022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is Alzheimer's disease a result of presynaptic failure? Synaptic dysfunctions induced by oligomeric beta-amyloid.
    Nimmrich V; Ebert U
    Rev Neurosci; 2009; 20(1):1-12. PubMed ID: 19526730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dendritic Spines in Alzheimer's Disease: How the Actin Cytoskeleton Contributes to Synaptic Failure.
    Pelucchi S; Stringhi R; Marcello E
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32019166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EphA4 loss improves social memory performance and alters dendritic spine morphology without changes in amyloid pathology in a mouse model of Alzheimer's disease.
    Poppe L; Rué L; Timmers M; Lenaerts A; Storm A; Callaerts-Vegh Z; Courtand G; de Boer A; Smolders S; Van Damme P; Van Den Bosch L; D'Hooge R; De Strooper B; Robberecht W; Lemmens R
    Alzheimers Res Ther; 2019 Dec; 11(1):102. PubMed ID: 31831046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic Microtubules in Alzheimer's Disease: Association with Dendritic Spine Pathology.
    Pchitskaya EI; Zhemkov VA; Bezprozvanny IB
    Biochemistry (Mosc); 2018 Sep; 83(9):1068-1074. PubMed ID: 30472945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alzheimer's disease and Abeta toxicity: from top to bottom.
    Small DH; Mok SS; Bornstein JC
    Nat Rev Neurosci; 2001 Aug; 2(8):595-8. PubMed ID: 11484003
    [No Abstract]   [Full Text] [Related]  

  • 11. Progressive accumulation of amyloid-beta oligomers in Alzheimer's disease and in amyloid precursor protein transgenic mice is accompanied by selective alterations in synaptic scaffold proteins.
    Pham E; Crews L; Ubhi K; Hansen L; Adame A; Cartier A; Salmon D; Galasko D; Michael S; Savas JN; Yates JR; Glabe C; Masliah E
    FEBS J; 2010 Jul; 277(14):3051-67. PubMed ID: 20573181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of neuronal dystrophy induced by fibrillar amyloid beta: implications for Alzheimer's disease.
    Grace EA; Rabiner CA; Busciglio J
    Neuroscience; 2002; 114(1):265-73. PubMed ID: 12207971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nicotinic receptors, amyloid-beta, and synaptic failure in Alzheimer's disease.
    Jürgensen S; Ferreira ST
    J Mol Neurosci; 2010 Jan; 40(1-2):221-9. PubMed ID: 19690986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synaptic changes in Alzheimer's disease and its models.
    Pozueta J; Lefort R; Shelanski ML
    Neuroscience; 2013 Oct; 251():51-65. PubMed ID: 22687952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired regulation of synaptic actin cytoskeleton in Alzheimer's disease.
    Penzes P; Vanleeuwen JE
    Brain Res Rev; 2011 Jun; 67(1-2):184-92. PubMed ID: 21276817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cytoskeletal alterations in Alzheimer's disease: the "skeleton" of therapeutic hope?].
    Fodor KE; Pákáski M; Santha P; Janka Z; Kálmán J
    Neuropsychopharmacol Hung; 2011 Sep; 13(3):163-71. PubMed ID: 21876225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amyloid-β oligomers synaptotoxicity: The emerging role of EphA4/c-Abl signaling in Alzheimer's disease.
    Vargas LM; Cerpa W; Muñoz FJ; Zanlungo S; Alvarez AR
    Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt A):1148-1159. PubMed ID: 29378302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aβ mediates F-actin disassembly in dendritic spines leading to cognitive deficits in Alzheimer's disease.
    Kommaddi RP; Das D; Karunakaran S; Nanguneri S; Bapat D; Ray A; Shaw E; Bennett DA; Nair D; Ravindranath V
    J Neurosci; 2018 Jan; 38(5):1085-1099. PubMed ID: 29246925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Layer-specific alterations to CA1 dendritic spines in a mouse model of Alzheimer's disease.
    Merino-Serrais P; Knafo S; Alonso-Nanclares L; Fernaud-Espinosa I; DeFelipe J
    Hippocampus; 2011 Oct; 21(10):1037-44. PubMed ID: 20848609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The potential role of rho GTPases in Alzheimer's disease pathogenesis.
    Bolognin S; Lorenzetto E; Diana G; Buffelli M
    Mol Neurobiol; 2014 Oct; 50(2):406-22. PubMed ID: 24452387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.